A Clinical View of BDNF-TrkB Signaling in the Treatment of Major Depression

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|2|3|186-189

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.2, Iss.3, 2007-09, pp. : 186-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BDNF/TrkB Content and Interaction with Gastrin-Releasing Peptide Receptor Blockade in Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 5-6, 2011-04 ,pp. : 430-439

Karger

Access to resources Recommend Favorite

MPTP‐induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF‐TrkB pathway

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 9, 2015-05 ,pp. : 2354-2368

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences

By Sicras-Mainar Antoni   Navarro-Artieda Ruth   Blanca-Tamayo Milagrosa   Gimeno-de la Fuente Victoria   Salvatella-Pasant Jordi  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2757-2764

Informa Healthcare

Access to resources Recommend Favorite

Clinical Correlates of Major Depression in Cushing’s Disease

By  

Psychopathology, Vol. 31, Iss. 6, 1998-10 ,pp. : 302-306

Karger

Access to resources Recommend Favorite

The Treatment of Psychotic Major Depression: Is There a Role for Adjunctive Psychotherapy?

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 5, 2007-08 ,pp. : 271-277

Karger

Access to resources Recommend Favorite